nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—ALB—focal segmental glomerulosclerosis	0.355	1	CbGaD
Fluorouracil—ABCC3—Cyclosporine—focal segmental glomerulosclerosis	0.265	0.561	CbGbCtD
Fluorouracil—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.109	0.23	CbGbCtD
Fluorouracil—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0579	0.123	CbGbCtD
Fluorouracil—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0404	0.0856	CbGbCtD
Fluorouracil—Cerebellar ataxia—Cyclosporine—focal segmental glomerulosclerosis	0.0231	0.294	CcSEcCtD
Fluorouracil—UPP2—kidney—focal segmental glomerulosclerosis	0.0103	0.119	CbGeAlD
Fluorouracil—UPP2—cortex of kidney—focal segmental glomerulosclerosis	0.01	0.116	CbGeAlD
Fluorouracil—UMPS—nephron tubule—focal segmental glomerulosclerosis	0.00663	0.0771	CbGeAlD
Fluorouracil—TYMP—endothelium—focal segmental glomerulosclerosis	0.00625	0.0726	CbGeAlD
Fluorouracil—UPP1—nephron tubule—focal segmental glomerulosclerosis	0.00608	0.0707	CbGeAlD
Fluorouracil—UMPS—cortex of kidney—focal segmental glomerulosclerosis	0.00568	0.066	CbGeAlD
Fluorouracil—UPP1—cortex of kidney—focal segmental glomerulosclerosis	0.00521	0.0605	CbGeAlD
Fluorouracil—DPYD—nephron tubule—focal segmental glomerulosclerosis	0.00494	0.0574	CbGeAlD
Fluorouracil—DPYD—cortex of kidney—focal segmental glomerulosclerosis	0.00423	0.0491	CbGeAlD
Fluorouracil—SLC22A7—kidney—focal segmental glomerulosclerosis	0.00251	0.0291	CbGeAlD
Fluorouracil—TYMS—nephron tubule—focal segmental glomerulosclerosis	0.00246	0.0285	CbGeAlD
Fluorouracil—TYMP—cortex of kidney—focal segmental glomerulosclerosis	0.00245	0.0285	CbGeAlD
Fluorouracil—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.00244	0.0284	CbGeAlD
Fluorouracil—ABCC5—nephron tubule—focal segmental glomerulosclerosis	0.0024	0.0279	CbGeAlD
Fluorouracil—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.0301	CcSEcCtD
Fluorouracil—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.0276	CcSEcCtD
Fluorouracil—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.0273	CcSEcCtD
Fluorouracil—TYMS—cortex of kidney—focal segmental glomerulosclerosis	0.0021	0.0244	CbGeAlD
Fluorouracil—SLC29A1—kidney—focal segmental glomerulosclerosis	0.00193	0.0225	CbGeAlD
Fluorouracil—SLC29A1—cortex of kidney—focal segmental glomerulosclerosis	0.00188	0.0219	CbGeAlD
Fluorouracil—ABCC3—kidney—focal segmental glomerulosclerosis	0.00177	0.0206	CbGeAlD
Fluorouracil—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.022	CcSEcCtD
Fluorouracil—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.0218	CcSEcCtD
Fluorouracil—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00166	0.0193	CbGeAlD
Fluorouracil—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0195	CcSEcCtD
Fluorouracil—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0192	CcSEcCtD
Fluorouracil—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0192	CcSEcCtD
Fluorouracil—ABCC4—kidney—focal segmental glomerulosclerosis	0.00146	0.017	CbGeAlD
Fluorouracil—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00142	0.0165	CbGeAlD
Fluorouracil—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0162	CcSEcCtD
Fluorouracil—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0162	CcSEcCtD
Fluorouracil—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0154	CcSEcCtD
Fluorouracil—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00117	0.0136	CbGeAlD
Fluorouracil—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0144	CcSEcCtD
Fluorouracil—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00106	0.0123	CbGeAlD
Fluorouracil—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0134	CcSEcCtD
Fluorouracil—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0132	CcSEcCtD
Fluorouracil—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0131	CcSEcCtD
Fluorouracil—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0128	CcSEcCtD
Fluorouracil—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.0118	CcSEcCtD
Fluorouracil—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.0113	CcSEcCtD
Fluorouracil—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000875	0.0111	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000813	0.0103	CcSEcCtD
Fluorouracil—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000784	0.00995	CcSEcCtD
Fluorouracil—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00078	0.0099	CcSEcCtD
Fluorouracil—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00078	0.0099	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000769	0.00976	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000764	0.0097	CcSEcCtD
Fluorouracil—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000764	0.0097	CcSEcCtD
Fluorouracil—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.00965	CcSEcCtD
Fluorouracil—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00962	CcSEcCtD
Fluorouracil—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00962	CcSEcCtD
Fluorouracil—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00933	CcSEcCtD
Fluorouracil—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00928	CcSEcCtD
Fluorouracil—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.00893	CcSEcCtD
Fluorouracil—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000702	0.00891	CcSEcCtD
Fluorouracil—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00888	CcSEcCtD
Fluorouracil—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.00884	CcSEcCtD
Fluorouracil—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.00882	CcSEcCtD
Fluorouracil—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.000672	0.0837	CbGpPWpGaD
Fluorouracil—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00794	CcSEcCtD
Fluorouracil—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000619	0.00785	CcSEcCtD
Fluorouracil—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000574	0.00729	CcSEcCtD
Fluorouracil—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00715	CcSEcCtD
Fluorouracil—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00692	CcSEcCtD
Fluorouracil—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000528	0.0067	CcSEcCtD
Fluorouracil—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.00658	CcSEcCtD
Fluorouracil—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.00658	CcSEcCtD
Fluorouracil—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.0065	CcSEcCtD
Fluorouracil—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00636	CcSEcCtD
Fluorouracil—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00631	CcSEcCtD
Fluorouracil—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000497	0.00631	CcSEcCtD
Fluorouracil—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00627	CcSEcCtD
Fluorouracil—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00619	CcSEcCtD
Fluorouracil—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.00618	CcSEcCtD
Fluorouracil—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00602	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00575	CcSEcCtD
Fluorouracil—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00571	CcSEcCtD
Fluorouracil—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000447	0.00567	CcSEcCtD
Fluorouracil—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000443	0.00563	CcSEcCtD
Fluorouracil—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.00561	CcSEcCtD
Fluorouracil—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00556	CcSEcCtD
Fluorouracil—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000432	0.00549	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000429	0.00545	CcSEcCtD
Fluorouracil—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000425	0.0054	CcSEcCtD
Fluorouracil—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.0052	CcSEcCtD
Fluorouracil—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.00501	CcSEcCtD
Fluorouracil—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.00499	CcSEcCtD
Fluorouracil—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00465	CcSEcCtD
Fluorouracil—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.00447	CcSEcCtD
Fluorouracil—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.00432	CcSEcCtD
Fluorouracil—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.00417	CcSEcCtD
Fluorouracil—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.00401	CcSEcCtD
Fluorouracil—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.00398	CcSEcCtD
Fluorouracil—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000313	0.00398	CcSEcCtD
Fluorouracil—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00395	CcSEcCtD
Fluorouracil—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.00375	CcSEcCtD
Fluorouracil—TYMS—G1/S-Specific Transcription—PCNA—focal segmental glomerulosclerosis	0.000288	0.0359	CbGpPWpGaD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000268	0.0334	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000231	0.0288	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.00022	0.0275	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—PODXL—focal segmental glomerulosclerosis	0.000191	0.0238	CbGpPWpGaD
Fluorouracil—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000181	0.0226	CbGpPWpGaD
Fluorouracil—ABCC3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000177	0.022	CbGpPWpGaD
Fluorouracil—TYMS—E2F mediated regulation of DNA replication—PCNA—focal segmental glomerulosclerosis	0.000169	0.0211	CbGpPWpGaD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000138	0.0172	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000125	0.0155	CbGpPWpGaD
Fluorouracil—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000113	0.0141	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000109	0.0136	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.000109	0.0136	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000105	0.0131	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000103	0.0128	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	9.98e-05	0.0124	CbGpPWpGaD
Fluorouracil—ABCC3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	9.24e-05	0.0115	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	8.88e-05	0.0111	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—ALB—focal segmental glomerulosclerosis	8.86e-05	0.011	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	8.22e-05	0.0102	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	7.8e-05	0.00972	CbGpPWpGaD
Fluorouracil—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	7.54e-05	0.0094	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	7.05e-05	0.00879	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	7.04e-05	0.00877	CbGpPWpGaD
Fluorouracil—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	6.93e-05	0.00863	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	6.68e-05	0.00832	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—PCNA—focal segmental glomerulosclerosis	6.51e-05	0.00812	CbGpPWpGaD
Fluorouracil—TYMS—E2F transcription factor network—SERPINE1—focal segmental glomerulosclerosis	6.35e-05	0.00791	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	6.16e-05	0.00767	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—LIPC—focal segmental glomerulosclerosis	5.8e-05	0.00723	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	5.71e-05	0.00711	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—FN1—focal segmental glomerulosclerosis	5.52e-05	0.00688	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—PCNA—focal segmental glomerulosclerosis	5.49e-05	0.00684	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.39e-05	0.00672	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.39e-05	0.00672	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ACTN4—focal segmental glomerulosclerosis	5.29e-05	0.00659	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	5.26e-05	0.00655	CbGpPWpGaD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	5.13e-05	0.00639	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CTGF—focal segmental glomerulosclerosis	5.11e-05	0.00637	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	4.93e-05	0.00614	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.79e-05	0.00596	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.75e-05	0.00592	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.75e-05	0.00592	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.71e-05	0.00587	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.67e-05	0.00581	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	4.65e-05	0.00579	CbGpPWpGaD
Fluorouracil—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	4.6e-05	0.00573	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	4.59e-05	0.00572	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—ALB—focal segmental glomerulosclerosis	4.58e-05	0.00571	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.38e-05	0.00545	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.38e-05	0.00545	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	4.38e-05	0.00545	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	4.37e-05	0.00544	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.16e-05	0.00518	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	4.12e-05	0.00513	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.93e-05	0.0049	CbGpPWpGaD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.89e-05	0.00485	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—LIPC—focal segmental glomerulosclerosis	3.74e-05	0.00466	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—LIPC—focal segmental glomerulosclerosis	3.74e-05	0.00466	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	3.54e-05	0.00441	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—LPL—focal segmental glomerulosclerosis	3.54e-05	0.00441	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	3.44e-05	0.00429	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	3.35e-05	0.00418	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CTGF—focal segmental glomerulosclerosis	3.29e-05	0.0041	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CTGF—focal segmental glomerulosclerosis	3.29e-05	0.0041	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—LPL—focal segmental glomerulosclerosis	3.29e-05	0.0041	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—LPL—focal segmental glomerulosclerosis	3.29e-05	0.0041	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.17e-05	0.00395	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.03e-05	0.00378	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.03e-05	0.00378	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AGT—focal segmental glomerulosclerosis	3.03e-05	0.00377	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	2.98e-05	0.00371	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	2.9e-05	0.00361	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	2.82e-05	0.00352	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AGT—focal segmental glomerulosclerosis	2.82e-05	0.00351	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AGT—focal segmental glomerulosclerosis	2.82e-05	0.00351	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	2.76e-05	0.00344	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.73e-05	0.0034	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—LIPC—focal segmental glomerulosclerosis	2.66e-05	0.00332	CbGpPWpGaD
Fluorouracil—ABCC5—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.59e-05	0.00322	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	2.54e-05	0.00316	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.53e-05	0.00316	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	2.5e-05	0.00311	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	2.45e-05	0.00305	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	2.42e-05	0.00302	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	2.39e-05	0.00298	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	2.38e-05	0.00297	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CTGF—focal segmental glomerulosclerosis	2.35e-05	0.00292	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.34e-05	0.00291	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—ALB—focal segmental glomerulosclerosis	2.32e-05	0.0029	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—LPL—focal segmental glomerulosclerosis	2.28e-05	0.00284	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—LPL—focal segmental glomerulosclerosis	2.28e-05	0.00284	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.23e-05	0.00278	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	2.23e-05	0.00278	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.22e-05	0.00276	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.2e-05	0.00274	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.16e-05	0.00269	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ALB—focal segmental glomerulosclerosis	2.16e-05	0.00269	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—ALB—focal segmental glomerulosclerosis	2.16e-05	0.00269	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.12e-05	0.00264	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	2.08e-05	0.00259	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	2.04e-05	0.00254	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	2.03e-05	0.00253	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	2.01e-05	0.00251	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	1.98e-05	0.00247	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.98e-05	0.00246	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AGT—focal segmental glomerulosclerosis	1.95e-05	0.00243	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AGT—focal segmental glomerulosclerosis	1.95e-05	0.00243	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	1.93e-05	0.0024	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.91e-05	0.00237	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	1.86e-05	0.00232	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.86e-05	0.00231	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—PCNA—focal segmental glomerulosclerosis	1.8e-05	0.00224	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.79e-05	0.00223	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—LIPC—focal segmental glomerulosclerosis	1.76e-05	0.00219	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—LPL—focal segmental glomerulosclerosis	1.63e-05	0.00203	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.61e-05	0.00201	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	1.6e-05	0.002	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CTGF—focal segmental glomerulosclerosis	1.55e-05	0.00193	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.55e-05	0.00193	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—LIPC—focal segmental glomerulosclerosis	1.53e-05	0.00191	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ALB—focal segmental glomerulosclerosis	1.5e-05	0.00187	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ALB—focal segmental glomerulosclerosis	1.5e-05	0.00187	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	1.43e-05	0.00178	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.43e-05	0.00178	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AGT—focal segmental glomerulosclerosis	1.39e-05	0.00173	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—LIPC—focal segmental glomerulosclerosis	1.36e-05	0.0017	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CTGF—focal segmental glomerulosclerosis	1.35e-05	0.00168	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.32e-05	0.00165	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	1.31e-05	0.00163	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.31e-05	0.00163	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.29e-05	0.0016	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—LPL—focal segmental glomerulosclerosis	1.28e-05	0.0016	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	1.26e-05	0.00157	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	1.25e-05	0.00156	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.25e-05	0.00155	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-05	0.00155	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CTGF—focal segmental glomerulosclerosis	1.2e-05	0.0015	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.19e-05	0.00149	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	1.15e-05	0.00143	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.13e-05	0.00141	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.13e-05	0.0014	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—LPL—focal segmental glomerulosclerosis	1.12e-05	0.00139	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	1.11e-05	0.00138	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.11e-05	0.00138	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.08e-05	0.00135	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.08e-05	0.00134	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—LPL—focal segmental glomerulosclerosis	1.07e-05	0.00134	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ALB—focal segmental glomerulosclerosis	1.07e-05	0.00133	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.05e-05	0.00131	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	1.05e-05	0.00131	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.01e-05	0.00126	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NOS2—focal segmental glomerulosclerosis	1e-05	0.00125	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.94e-06	0.00124	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CTGF—focal segmental glomerulosclerosis	9.93e-06	0.00124	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.65e-06	0.0012	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	9.6e-06	0.0012	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.54e-06	0.00119	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.49e-06	0.00118	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—LPL—focal segmental glomerulosclerosis	9.34e-06	0.00116	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	9.22e-06	0.00115	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AGT—focal segmental glomerulosclerosis	9.18e-06	0.00114	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.15e-06	0.00114	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.07e-06	0.00113	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.82e-06	0.0011	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOS2—focal segmental glomerulosclerosis	8.71e-06	0.00109	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SERPINE1—focal segmental glomerulosclerosis	8.43e-06	0.00105	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—LPL—focal segmental glomerulosclerosis	8.32e-06	0.00104	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AGT—focal segmental glomerulosclerosis	7.99e-06	0.000996	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	7.78e-06	0.000969	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.77e-06	0.000968	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.54e-06	0.000939	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SERPINE1—focal segmental glomerulosclerosis	7.33e-06	0.000914	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AGT—focal segmental glomerulosclerosis	7.12e-06	0.000887	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	7.07e-06	0.000881	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ALB—focal segmental glomerulosclerosis	7.04e-06	0.000878	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—LPL—focal segmental glomerulosclerosis	6.88e-06	0.000858	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	6.85e-06	0.000853	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.65e-06	0.000829	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.64e-06	0.000827	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.63e-06	0.000826	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.61e-06	0.000824	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.58e-06	0.00082	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.31e-06	0.000786	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.22e-06	0.000775	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ALB—focal segmental glomerulosclerosis	6.13e-06	0.000764	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AGT—focal segmental glomerulosclerosis	5.89e-06	0.000734	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	5.82e-06	0.000725	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.73e-06	0.000714	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	5.71e-06	0.000712	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.66e-06	0.000705	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	5.64e-06	0.000703	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.63e-06	0.000701	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—focal segmental glomerulosclerosis	5.46e-06	0.00068	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.38e-06	0.000671	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—focal segmental glomerulosclerosis	5.32e-06	0.000663	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	4.83e-06	0.000602	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	4.8e-06	0.000598	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	4.75e-06	0.000592	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	4.75e-06	0.000592	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—focal segmental glomerulosclerosis	4.63e-06	0.000577	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.61e-06	0.000574	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.6e-06	0.000573	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—focal segmental glomerulosclerosis	4.52e-06	0.000563	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.34e-06	0.000541	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	4.31e-06	0.000537	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	4.25e-06	0.00053	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	4.23e-06	0.000527	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	4.06e-06	0.000506	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.94e-06	0.00049	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.93e-06	0.00049	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.92e-06	0.000488	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.89e-06	0.000485	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	3.69e-06	0.00046	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.53e-06	0.00044	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.46e-06	0.000431	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.36e-06	0.000418	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.19e-06	0.000397	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	3.12e-06	0.000388	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.02e-06	0.000376	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3e-06	0.000374	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.96e-06	0.000368	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	2.95e-06	0.000367	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	2.93e-06	0.000365	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	2.83e-06	0.000353	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.72e-06	0.000339	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.52e-06	0.000314	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	2.51e-06	0.000312	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.4e-06	0.000299	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.05e-06	0.000256	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.05e-06	0.000255	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.93e-06	0.000241	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.75e-06	0.000218	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.57e-06	0.000196	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.35e-06	0.000168	CbGpPWpGaD
